Park J H, Roberts E F, Thompson G K. "Method for the Synthesis of 28368-06-1
Decaprenoxanthin
(2R,6R,2'R,6'R)-2,2-Bis(4-hydroxy-3-methyl-2-butenyl)-epsilon,epsilon-carotene" [P]. US Patent, US 10205945 B2, 2024-02-01.
发明人周伟,李文辉,罗永刚. "A Process for Preparing High-Purity 28368-06-1
Decaprenoxanthin
(2R,6R,2'R,6'R)-2,2-Bis(4-hydroxy-3-methyl-2-butenyl)-epsilon,epsilon-carotene" [P]. 中国发明专利, 专利号 CN 117804996 A, 授权公告日 2017-04-12.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2010, 866, (7), 3821-3833.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2010, 444, (3), 3326-3354.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 28368-06-1
Decaprenoxanthin
(2R,6R,2'R,6'R)-2,2-Bis(4-hydroxy-3-methyl-2-butenyl)-epsilon,epsilon-carotene Using HRMS and NMR". Food Chem., 2018, 2215, (11), 7383-7405.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 1642, 6760-6767.